BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22387059)

  • 1. Increased expression of T cell immunoglobulin- and mucin domain-containing molecule-3 on natural killer cells in atherogenesis.
    Hou N; Zhao D; Liu Y; Gao L; Liang X; Liu X; Gai X; Zhang X; Zhu F; Ni M; Zhang Y; Sun W; Ma C
    Atherosclerosis; 2012 May; 222(1):67-73. PubMed ID: 22387059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased CD160 expression on circulating natural killer cells in atherogenesis.
    Zuo J; Shan Z; Zhou L; Yu J; Liu X; Gao Y
    J Transl Med; 2015 Jun; 13():188. PubMed ID: 26071079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.
    Ju Y; Hou N; Meng J; Wang X; Zhang X; Zhao D; Liu Y; Zhu F; Zhang L; Sun W; Liang X; Gao L; Ma C
    J Hepatol; 2010 Mar; 52(3):322-9. PubMed ID: 20133006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer.
    Zheng Y; Li Y; Lian J; Yang H; Li F; Zhao S; Qi Y; Zhang Y; Huang L
    J Transl Med; 2019 May; 17(1):165. PubMed ID: 31109341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma.
    Xu L; Huang Y; Tan L; Yu W; Chen D; Lu C; He J; Wu G; Liu X; Zhang Y
    Int Immunopharmacol; 2015 Dec; 29(2):635-641. PubMed ID: 26428847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tim-3 expression on peripheral monocytes and CD3+CD16/CD56+natural killer-like T cells in patients with chronic hepatitis B.
    Rong YH; Wan ZH; Song H; Li YL; Zhu B; Zang H; Zhao Y; Liu HL; Zhang AM; Xiao L; Xin SJ; You SL
    Tissue Antigens; 2014 Feb; 83(2):76-81. PubMed ID: 24397461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Significance of Abnormal Tim-3 Expression on NK Cells from Patients with Gastric Cancer.
    Wang Z; Zhu J; Gu H; Yuan Y; Zhang B; Zhu D; Zhou J; Zhu Y; Chen W
    Immunol Invest; 2015; 44(6):578-89. PubMed ID: 26214042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.
    Cheng YQ; Ren JP; Zhao J; Wang JM; Zhou Y; Li GY; Moorman JP; Yao ZQ
    Immunology; 2015 Aug; 145(4):485-97. PubMed ID: 25772938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3.
    Golden-Mason L; Waasdorp Hurtado CE; Cheng L; Rosen HR
    Clin Immunol; 2015 May; 158(1):114-25. PubMed ID: 25797693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors.
    Komita H; Koido S; Hayashi K; Kan S; Ito M; Kamata Y; Suzuki M; Homma S
    Oncol Rep; 2015 Oct; 34(4):2099-105. PubMed ID: 26239720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tim-3 Is Upregulated in NK Cells during Early Pregnancy and Inhibits NK Cytotoxicity toward Trophoblast in Galectin-9 Dependent Pathway.
    Sun J; Yang M; Ban Y; Gao W; Song B; Wang Y; Zhang Y; Shao Q; Kong B; Qu X
    PLoS One; 2016; 11(1):e0147186. PubMed ID: 26789128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins reduce the expressions of Tim-3 on NK cells and NKT cells in atherosclerosis.
    Zhang N; Zhang M; Liu RT; Zhang P; Yang CL; Yue LT; Li H; Li YK; Duan RS
    Eur J Pharmacol; 2018 Feb; 821():49-56. PubMed ID: 29288118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis.
    Qiu MK; Wang SC; Dai YX; Wang SQ; Ou JM; Quan ZW
    PLoS One; 2015; 10(6):e0128523. PubMed ID: 26035207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood TIM-3 positive NK and CD8+ T cells throughout pregnancy: TIM-3/galectin-9 interaction and its possible role during pregnancy.
    Meggyes M; Miko E; Polgar B; Bogar B; Farkas B; Illes Z; Szereday L
    PLoS One; 2014; 9(3):e92371. PubMed ID: 24651720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated Expression of Tim-3 and NKp30 Receptors on NK Cells of Patients with Chronic Lymphocytic Leukemia.
    Hadadi L; Hafezi M; Amirzargar AA; Sharifian RA; Abediankenari S; Asgarian-Omran H
    Oncol Res Treat; 2019; 42(4):202-208. PubMed ID: 30870839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tim-3 and PD-1 blocking cannot restore the functional properties of natural killer cells in early clinical stages of chronic lymphocytic leukemia: An
    Astaneh M; Rezazadeh H; Hossein-Nataj H; Shekarriz R; Zaboli E; Shabani M; Asgarian-Omran H
    J Cancer Res Ther; 2022; 18(3):704-711. PubMed ID: 35900543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tim-3 negatively mediates natural killer cell function in LPS-induced endotoxic shock.
    Hou H; Liu W; Wu S; Lu Y; Peng J; Zhu Y; Lu Y; Wang F; Sun Z
    PLoS One; 2014; 9(10):e110585. PubMed ID: 25337993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade.
    da Silva IP; Gallois A; Jimenez-Baranda S; Khan S; Anderson AC; Kuchroo VK; Osman I; Bhardwaj N
    Cancer Immunol Res; 2014 May; 2(5):410-22. PubMed ID: 24795354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of Tim-3 on Peripheral CD56(+) NK Cells and ItsCorrelation with Liver Fibrosis in Patients withAdvanced Schistosomiasis].
    WU QW; ZHU X; FU X; YANG JS; CAO ZG; PU C
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2015 Oct; 33(5):346-50. PubMed ID: 26931038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.
    Gleason MK; Lenvik TR; McCullar V; Felices M; O'Brien MS; Cooley SA; Verneris MR; Cichocki F; Holman CJ; Panoskaltsis-Mortari A; Niki T; Hirashima M; Blazar BR; Miller JS
    Blood; 2012 Mar; 119(13):3064-72. PubMed ID: 22323453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.